Stability-indicating RP-HPLC method for analysis of atorvastatin in bulk drug, marketed tablet and nanoemulsion formulation

Journal of the Chilean Chemical Society

Volumn 55, Issue 2, 2010, Pages 184-188

  Mustafa, Gulam ^a   Azeem, Adnan ^a   Ahmad, Farhan J ^a   Khan, Zeenat I ^a   Shakeel, Faiyaz ^b   Talegaonkar, Sushma ^a  

^a HAMDARD UNIVERSITY   (India)

^b AL ARAB MEDICAL UNIVERSITY   (Libyan Arab Jamahiriya)

Author keywords

Atorvastatin; ICH guidelines; Nanoemulsion; RP HPLC; Tablets

Indexed keywords

EID: 77956897757     PISSN: 07179324     EISSN: 07179707     Source Type: Journal    
DOI: 10.4067/S0717-97072010000200008     Document Type: Article

References (31)

1. N. Jain, R. Raghuvanshi, D. Jain, Ind. J. Pharm. Sci. 70, 263, (2008).
2. A. P. Lea, D. McTavish, Drugs 53, 828, (1997)..
3. S. Shafiq, F. Shakeel, S. Talegaonkar, F. J. Ahmed, R. K. Khar, M. Ali, Eur. J. Pharm. Biopharm. 66, 227, (2007).
4. F. Shakeel, S. Baboota, A. Ahuja, J. Ali, S. Shafiq, J. Nanobitech. 6, E8, (2008).
5. F. Shakeel, S. Baboota, A. Ahuja, J. Ali, S. Shafiq, J. Drug Target. 16, 733, (2008).
6. N. Erk, Anal. Lett. 36, 2699, (2008).
7. L. Novakova, S. A. Lopez, D. Solichova, D. Satisky, B. Kulichova, A. Horna, P. Solich, Talanta 78, 834, (2009).
8. S. S. Yadav, D. V. Mhaske, A. B. Kakad, B. D. Patil, S. S. Kadam, S. R. Dhaneshwar, Ind. J. Pharm. Sci. 67, 182, (2005).
9. W. W. Bullen, R. A. Miller, R. N. Hayes, J. Am. Soc. Mass Spectrom. 10, 55, (1999).
10. M. Jemal, Z. Ouyang, B. C. Chen, D. Teitz, Rapid Commun. Mass Spectrom. 13, 1003, (1999).
11. A. G. Altuntas, N. Erk, J. Liq. Chromatogr. Rel. Technol. 27, 89, (2004).
12. G. Bahrami, B. Mohammadi, S. Mirzaeei, A. Kiani, J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 826, 41, (2005).
13. M. Hermann, H. Christensen, J. L. Reubsaet, Anal. Bioanal. Chem. 382, 1242, (2005).
14. V. Borek-Dohalsky, J. Huclova, B. Barrett, B. Nemec, I. Ulc, I. Jelinek, Anal. Bioanal. Chem. 386, 275, (2006).
15. R. Nirogi, K. Mudigonda, V. Kandikere, J. Pharm. Biomed. Anal. 44, 379, (2007).
16. S. Erturk, A. E. Sevinc, L. Ersoy, S. Ficicioglu, J. Pharm. Biomed. Anal. 33, 1017, (2003).
17. B. G. Chaudhari, N. M. Patel, P. B. Shah, Chem. Pharm. Bull. 55, 241, (2007).
18. M. K. Pasha, S. Muzeeb, S. J. Basha, D. Shashikumar, R. Mullangi, N. R. Srinivas, Biomed. Chromatogr. 20, 282, (2006).
19. A. Mohammadi, N. Rezanour, D. M. Ansari, B. F. Ghorbani, M. Hashem, R. B. Walker, J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 846, 215, (2007).
20. D. A. Shah, K. K. Bhatt, R. S. Mehta, M. B. Shankar, S. L. Baldania, T. R. Gandhi, Ind. J. Pharm. Sci. 69, 546, (2007).
21. T. Shivakumar, R. Manavalan, C. Muralidharan, K. Valliappan, J. Sep. Sci. 30, 3143, (2007).
22. Ismail, R. Rajavel, M. Ganesh, M. Jgadeeswaran, K. Srinivasan, J. Valarmathi, T. Shivakumar, Asian J. Res. Chem. 1, 40, (2008).
23. U. Seshachalam, C. B. Kothapally, J. Liq. Chromatogr. Rel. Technol. 31, 714, (2008).
24. X. S. Miao, C. D. Metcalfe, J. Chromatogr. A. 998, 133, (2003).
25. R. P. Shah, V. Kumar, S. Singh, Rapid Commun. Mass Spectrom. 22, 613, (2008).
26. H. R. Shen, Z. D. Li, M. K. Zhong, Pharmazie 61, 18, (2006).
27. H. Shen, M. Zhong, J. Pharm. Pharmacol. 58, 1183, (2006).
28. A. Zarghi, A. Shafaati, S. M. Foroutan, A. Khoddam, Arzneimittelforschung. 55, 451, (2005).
29. B. Stanisz, L. Kania, Acta Pol. Pharm. 63, 471, (2006).
30. International Conference on Harmonization (ICH) of technical requirements for registration of pharmaceuticals for human use: Harmonized Triplicate Guideline on Validation of Analytical procedures: Methodology (November 1996) ICH Steering Committee IFPMA, Switzerland
31. M. Zaxariou, I. Panderi, J. Pharm. Biomed. Anal. 35, 41, (2004).